Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FUTURE study of prolonged-release furazidin for uncomplicated lower urinary tract infection
2021-000963-54Phase 2Terminated
- Sponsor
- Adamed Pharma
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of furazidin in Lower Urinary Tract Infection (LUTI) and urinary tract infection (UTI), sponsored by Adamed Pharma. Primary endpoint: Composite clinical and microbiological cure at test-of-cure. Started Jun 2021; status: terminated.
02
Drugs
furazidin
03
Conditions
Lower Urinary Tract Infection (LUTI)urinary tract infection (UTI)
Beyond the preview
Go deeper on 2021-000963-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000963-54.